FDA
- Status: approved
shu gan yi yang capsule simulation agent (shu gan yi yang capsule simulation agent) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Beijing Hospital of Traditional Chinese Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.